Oxygen tension-dependent variability in the cancer cell kinome impacts signaling pathways and response to targeted therapies

被引:0
|
作者
Adebayo, Adedeji K. [1 ,2 ,3 ]
Bhat-Nakshatri, Poornima [1 ]
Davis, Christopher [4 ]
Angus, Steven P. [3 ,4 ]
Erdogan, Cihat [5 ]
Gao, Hongyu [5 ]
Green, Nick [5 ]
Kumar, Brijesh [1 ,7 ]
Liu, Yunlong [5 ]
Nakshatri, Harikrishna [1 ,2 ,3 ,6 ]
机构
[1] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Indiana Univ Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA
[5] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[6] Roudebush VA Med Ctr, Indianapolis, IN 46202 USA
[7] Banaras Hindu Univ, Indian Inst Technol, Sch Biomed Engn, Varanasi 221005, Uttar Pradesh, India
基金
美国国家卫生研究院;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; MALIGNANT-TRANSFORMATION; THERAPEUTIC TARGET; TUMOR-CELLS; STEM; HYPOXIA; METASTASIS; ACTIVATION; EXPRESSION;
D O I
10.1016/j.isci.2024.110068
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Most cells in solid tumors are exposed to oxygen levels between 0.5% and 5%. We developed an approach that allows collection, processing, and evaluation of cancer and non -cancer cells under physioxia, while preventing exposure to ambient air. This aided comparison of baseline and drug -induced changes in signaling pathways under physioxia and ambient oxygen. Using tumor cells from transgenic models of breast cancer and cells from breast tissues of clinically breast cancer -free women, we demonstrate oxygen -dependent differences in cell preference for epidermal growth factor receptor (EGFR) or platelet -derived growth factor receptor beta (PDGFR b ) signaling. Physioxia caused PDGFR b- mediated activation of AKT and extracellular regulated kinase (ERK) that reduced sensitivity to EGFR and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) inhibition and maintained PDGFR b + epithelial-mesenchymal hybrid cells with potential cancer stem cell (CSC) properties. Cells in ambient air displayed differential EGFR activation and were more sensitive to targeted therapies. Our data emphasize the importance of oxygen considerations in preclinical cancer research to identify effective drug targets and develop combination therapy regimens.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Oxygen tension - dependent differences in cancer cell kinome
    Adebayo, Adedeji K.
    Kumar, Brijesh
    Davis, Christopher
    Angus, Steven P.
    Nakshatri, Harikrishna
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Assessing adaptation of the cancer kinome in response to targeted therapies
    Zawistowski, Jon S.
    Graves, Lee M.
    Johnson, Gary L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 765 - 769
  • [3] Immunosuppressive Signaling Pathways as Targeted Cancer Therapies
    Setlai, Botle Precious
    Hull, Rodney
    Bida, Meshack
    Durandt, Chrisna
    Mulaudzi, Thanyani Victor
    Chatziioannou, Aristotelis
    Dlamini, Zodwa
    BIOMEDICINES, 2022, 10 (03)
  • [4] Renal cancer: signaling pathways and advances in targeted therapies
    Jiang, Aimin
    Li, Jinxin
    He, Ziwei
    Liu, Ying
    Qiao, Kun
    Fang, Yu
    Qu, Le
    Luo, Peng
    Lin, Anqi
    Wang, Linhui
    MEDCOMM, 2024, 5 (08):
  • [5] Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer
    Giridharan, Madhuvanthi
    Rupani, Vasu
    Banerjee, Satarupa
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 2022 (05) : 193 - 206
  • [6] Targeted therapies in bladder cancer: signaling pathways, applications, and challenges
    Peng, Mei
    Chu, Xuetong
    Peng, Yan
    Li, Duo
    Zhang, Zhirong
    Wang, Weifan
    Zhou, Xiaochen
    Xiao, Di
    Yang, Xiaoping
    MEDCOMM, 2023, 4 (06):
  • [7] SRC kinase-mediated signaling pathways and targeted therapies in breast cancer
    Luo, Juan
    Zou, Hailin
    Guo, Yibo
    Tong, Tongyu
    Ye, Liping
    Zhu, Chengming
    Deng, Liang
    Wang, Bo
    Pan, Yihang
    Li, Peng
    BREAST CANCER RESEARCH, 2022, 24 (01)
  • [8] SRC kinase-mediated signaling pathways and targeted therapies in breast cancer
    Juan Luo
    Hailin Zou
    Yibo Guo
    Tongyu Tong
    Liping Ye
    Chengming Zhu
    Liang Deng
    Bo Wang
    Yihang Pan
    Peng Li
    Breast Cancer Research, 24
  • [9] Regulated cell death (RCD) in cancer: key pathways and targeted therapies
    Peng, Fu
    Liao, Minru
    Qin, Rui
    Zhu, Shiou
    Peng, Cheng
    Fu, Leilei
    Chen, Yi
    Han, Bo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [10] Regulated cell death (RCD) in cancer: key pathways and targeted therapies
    Fu Peng
    Minru Liao
    Rui Qin
    Shiou Zhu
    Cheng Peng
    Leilei Fu
    Yi Chen
    Bo Han
    Signal Transduction and Targeted Therapy, 7